May 2, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received a medical device license issued by Health Canada to market Cynosure’s advanced non-invasive body contouring product, SculpSure,...

May 2, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal second quarter ended March 31, 2018. Revenue of $789.3 million increased 10.3%, or 8.3% in constant...

May 1, 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: The Deutsche Bank 43rd Annual Health Care Conference in Boston, MA on Wednesday,...

More ›


SEC Filings
NASDAQHOLX